Cordia Myxa

Cordia myxa  Roxb. non Linn.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Synonym C. dichotoma Forst. f. C. obliqua Willd.
Family Boraginaceae.
Habitat Throughout India, wild and often planted.
English Sabestan Plum.
Ayurvedic Shleshmaataka, Shelu, Bahuvaara, Bahuvaaraka, Bhutvrkshak, Uddaalaka Shita, Picchila, Lisodaa.
Unani Sapistaan, Lasodaa.
Siddha / Tamil Naruvili.
Action Fruit—astringent, demulcent, expectorant, diuretic, anthelmintic, mucilaginous. Used in the diseases of the chest and urinary passage. Bark—used in dyspepsia and fevers. Kernels— externally applied to ringworm. Leaf—decoction used in cough and cold.
Taxonomic Cohort Genus Cordia (3 documented species); Family Boraginaceae (16 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Cordia myxa (taxonomically cited with authority Roxb. non Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Boraginaceae (primary family classification: Boraginaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy C. dichotoma Forst. f. C. obliqua Willd, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: Throughout India, wild and often planted.

Across classical and vernacular Indian systems of medicine, Cordia myxa is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Sabestan Plum; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Shleshmaataka, Shelu, Bahuvaara, Bahuvaaraka, Bhutvrkshak, Uddaalaka Shita, Picchila, Lisodaa; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Sapistaan, Lasodaa; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Naruvili. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Cordia myxa are: Fruit—astringent, demulcent, expectorant, diuretic, anthelmintic, mucilaginous. Used in the diseases of the chest and urinary passage. Bark—used in dyspepsia and fevers. Kernels— externally applied to ringworm. Leaf—decoction used in cough and cold. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Cordia myxa establish the following evidence base: The fruits contain Ca 55, P 275, Zn 2, Fe 6, Mn 2, Cr 0.2 and Cu 1.6 mg/100 g (Chromium is of therapeutic value in diabetes). Antinutritional factors are—phytic acid 355, phytate phosphorus 100 and oxalic acid 250 mg/100 g. The seeds contain alpha-amyrin and taxifolin-3, 5-dirhamnoside, which showed significant anti-inflammatory activity. EtOH (50%) of leaves and stems—antimicrobial; aerial parts— diuretic and hypothermic.

image2

Botanical Reference 1: Cordia myxa — Botanical specimen

image3

Botanical Reference 2: Cordia myxa — Botanical specimen

image3

Botanical Reference 3: Cordia myxa — Wikimedia Commons reference

4. Comparative Genus & Family Pharmacognosy

Taxonomically, the genus Cordia comprises 3 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Cordia rothii (Action: See C. myxa); Cordia wallichii (Action: Fruit—astringent, demulcent, expectorant. See C. myxa). Comparing Cordia myxa alongside its congeners in genus Cordia highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.

At the family level, Boraginaceae encompasses 16 documented medicinal species (0.88% of the 1,814-species flora). Other representative medicinal members of Boraginaceae include: Alkanna tinctoria (Alkanet), Anchusa italica (Gojihvikaa), Arnebia benthamii (Kashmiri Gaozabaan), Borago officinalis (Borage), Caccinia crassifolia. In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 16 medicinal species of family Boraginaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

In clinical and traditional dispensing, preparation and administration of Cordia myxa follow the plant-part modalities specified under its therapeutic action (Fruit—astringent, demulcent, expectorant, diuretic, anthelmintic, mucilaginous. Used in the diseases of the chest and urinary passage. Bark—used in dyspepsia and fevers. Kernels— externally applied to ringworm. Leaf—decoction used in cough and cold), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Cordia myxa integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top